Predictions
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€5.59
06.04.21
06.04.21
€7.00
06.04.22
06.04.22
-8.23%
19.04.21
19.04.21
Could be very worthwhile Investment >20% year
Biofrontera AG
Start price
Target price
Perf. (%)
€2.47
06.04.21
06.04.21
-
06.04.24
06.04.24
-84.62%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€47.88
06.04.21
06.04.21
-
06.04.22
06.04.22
-28.99%
17.04.21
17.04.21
Could be very worthwhile Investment >20% year
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€5.68
06.04.21
06.04.21
-
06.04.22
06.04.22
-61.56%
06.04.22
06.04.22
Charles River Labs Intl
Start price
Target price
Perf. (%)
€260.00
05.04.21
05.04.21
-
05.04.22
05.04.22
28.46%
03.11.21
03.11.21
AEterna Zentaris Inc.
Start price
Target price
Perf. (%)
€25.00
04.04.21
04.04.21
€0.000
04.04.22
04.04.22
-25.50%
18.04.21
18.04.21
Cti Biopharma Corp
Start price
Target price
Perf. (%)
€2.16
03.04.21
03.04.21
€1.00
03.04.22
03.04.22
-10.45%
26.06.21
26.06.21
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€70.00
03.04.21
03.04.21
€30.00
03.04.22
03.04.22
-24.26%
26.06.21
26.06.21
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€130.98
03.04.21
03.04.21
-
03.04.22
03.04.22
4.11%
17.04.21
17.04.21
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.59
03.04.21
03.04.21
-
03.04.22
03.04.22
-19.29%
17.04.21
17.04.21
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€2.25
31.03.21
31.03.21
-
31.03.22
31.03.22
-5.33%
04.04.21
04.04.21
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€4.22
30.03.21
30.03.21
-
30.03.22
30.03.22
25.59%
01.04.21
01.04.21
Probably not worthwhile Investment
China Pharma Holdings Inc.
Start price
Target price
Perf. (%)
€17.00
29.03.21
29.03.21
-
-51.47%
30.03.21
30.03.21
Probably not worthwhile Investment
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€7.24
25.03.21
25.03.21
€12.00
25.03.22
25.03.22
-26.11%
26.11.21
26.11.21
Merck KGaA
Start price
Target price
Perf. (%)
€144.40
25.03.21
25.03.21
€130.00
25.03.22
25.03.22
56.79%
14.12.21
14.12.21
Some uniques
Future proof or reliable business model
overvalued
Low dividend yield expected
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€152.98
25.03.21
25.03.21
€140.00
25.09.21
25.09.21
25.83%
28.06.21
28.06.21
Could be worthwhile Investment >10% per year
Known brand
Medium risks for its business
overvalued